Mayer B. Davidson

ORCID: 0000-0001-9194-8857
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Metabolism, Diabetes, and Cancer
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diabetes Management and Education
  • Diet and metabolism studies
  • Diabetes and associated disorders
  • Pancreatic function and diabetes
  • Pharmacology and Obesity Treatment
  • Adipose Tissue and Metabolism
  • Growth Hormone and Insulin-like Growth Factors
  • Muscle metabolism and nutrition
  • Chronic Disease Management Strategies
  • Clinical practice guidelines implementation
  • Regulation of Appetite and Obesity
  • Diet, Metabolism, and Disease
  • Blood Pressure and Hypertension Studies
  • Adipokines, Inflammation, and Metabolic Diseases
  • Metabolism and Genetic Disorders
  • Liver Disease Diagnosis and Treatment
  • Thyroid Disorders and Treatments
  • Neurological and metabolic disorders
  • Lipoproteins and Cardiovascular Health
  • Glycogen Storage Diseases and Myoclonus

Charles R. Drew University of Medicine and Science
2015-2024

Drew University
2023

University of California, Los Angeles
1990-2014

University of Calgary
2014

Tufts Medical Center
2014

Alliance for Canadian Health Outcomes Research in Diabetes
2014

University of Alberta
2014

Harley-Davidson (United States)
2013

The University of Melbourne
2007

Martin Luther King, Jr. Multi-Service Ambulatory Care Center
2006

The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with expectation that it would be updated, based on availability new interventions and evidence to establish their clinical role. authors continue endorse principles used develop its major features. We are sensitive risks changing cavalierly or too frequently, without compelling information. An update January 2008 specifically addressed safety issues surrounding thiazolidinediones. In this...

10.2337/dc08-9025 article EN Diabetes Care 2008-10-23

The epidemic of type 2 diabetes in the latter part 20th and early 21st century, recognition that achieving specific glycemic goals can substantially reduce morbidity, have made effective treatment hyperglycemia a top priority (1–3). While management hyperglycemia, hallmark metabolic abnormality associated with diabetes, has historically had center stage therapies directed at other coincident features, such as dyslipidemia, hypertension, hypercoagulability, obesity, insulin resistance, also...

10.2337/dc06-9912 article EN Diabetes Care 2006-07-27

The consensus algorithm for the management of type 2 diabetes was developed on behalf American Diabetes Association and European Study approximately 1 year ago (1,2). This evidence-based to help guide health care providers choose most appropriate treatment regimens from an ever-expanding list approved medications. authors continue endorse major features algorithm, including need achieve maintain glycemia within or as close nondiabetic range is safely possible, initiation lifestyle...

10.2337/dc08-9016 article EN Diabetes Care 2007-12-28

To test the hypothesis that glucose transport is rate limiting for skeletal muscle metabolism, intracellular free was measured in situ abdominal wall and liver were rapidly freeze-clamped removed from normal streptozocin-induced diabetic (STZ-D) Sprague-Dawley rats exposed to different concentrations of serum insulin achieved by 90-min clamps. Three groups anesthetized (n = 17) three STZ-D 19) animals studied. In each group, infusions adjusted expose basal, euglycemic-hyperinsulinemic,...

10.2337/diab.37.7.885 article EN Diabetes 1988-07-01

OBJECTIVE Low vitamin D levels predict the development of diabetes. This double-blind, randomized, control study in subjects with prediabetes and hypovitaminosis evaluated whether high doses for 1 year affected insulin secretion, sensitivity, RESEARCH DESIGN AND METHODS A total 1,551 ≥40 years age not known to have diabetes were screened A1C levels. Subjects 5.8–6.9% underwent an oral glucose tolerance test (OGTT). 25-OH (25-OHD) <30 ng/mL randomized receive weekly placebo (n = 53) or...

10.2337/dc12-1204 article EN cc-by-nc-nd Diabetes Care 2012-10-02

OBJECTIVE To document the quality of diabetes care provided to patients in a large health maintenance organization (HMO) from 1 January 1993 1994 and compare it standards American Diabetes Association (ADA). RESEARCH DESIGN AND METHODS meet Health Plan Employer Data Information Set (HEDIS) requirement, major HMO California identified 14,539 members with randomly selected 384 individuals for review. Charts were available on 353 these patients, after obtaining information HEDIS review,...

10.2337/diacare.19.6.601 article EN Diabetes Care 1996-06-01

Thirty percent of people with diabetes are undiagnosed (1), and up to 25% already have microvascular complications at diagnosis (2). The American Diabetes Association recommends screening adults ≥45 years age, especially those a BMI ≥25 kg/m2, 3-year intervals fasting plasma glucose (FPG) measurement (3). However, physicians infrequently use an FPG for screening. For example, in large health maintenance organization within the University Michigan system, 184 22 separate locations screened...

10.2337/dc07-0585 article EN Diabetes Care 2007-08-28

ContextNew criteria for the diagnosis of type 2 diabetes mellitus have recently been introduced that lowered diagnostic fasting plasma glucose (FPG) concentration from 7.8 to 7.0 mmol/L (140 126 mg/dL).ObjectiveTo determine if individuals with diagnosed by new FPG criterion would excessive glycosylation (elevated hemoglobin [HbA1c] levels).DefinitionsWe determined distribution HbA1c levels in using 4 classifications: (1) normal (FPG <6.1 [110 mg/dL]); (2) impaired 6.1-6.9 [110-125 (3) solely...

10.1001/jama.281.13.1203 article EN JAMA 1999-04-07

Treatment of patients with diabetes often falls short recommended process and outcome guidelines. To improve the quality provided care, a program (the Comprehensive Diabetes Care Service [CDCS]) using computerizing tracking recall system in conjunction nurses following protocols was implemented managed care setting. The impact this studied compared to another setting.Patients followed CDCS who completed education course were group model health maintenance organization (GMH) also course....

10.2337/diacare.21.7.1037 article EN Diabetes Care 1998-07-01

Hepatic plasma membranes prepared from rats rendered diabetic by streptozotocin bound approximately twice as much insulin per 50 mug protein control membranes. Glucagon binding of and was virtually identical. This increased not due to a nonspecific effect streptozotocin, decreased degradation slower dissociation its receptor, or selective higher yield the livers. Diabetic both showed negative cooperativity. Scatchard analysis suggested that difference in an enhanced capacity rather than...

10.1172/jci108618 article EN Journal of Clinical Investigation 1977-01-01
Coming Soon ...